RAPT Therapeutics
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-4.05-2.86-22.7210.68
Price/Sales ratio
410.6819.201.551.01
Earnings per Share (EPS)
$-2.63$-3.72$-0.47$1

Historical Multiples (2017 – 2023)

2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-6.45-6.23-14.01-9.01-14.74-7.86-8.15-6.23-11.51
Price/Sales ratio
N/AN/AN/A94.53263.84421.93N/A241.05167.79
Price/Book Value ratio
-3.013.518.244.575.392.626.472.134.98
Price/Cash Flow ratio
-6.93-6.83-16.99-11.77-16.48-9.10-9.81-7.38-14.38
Price/Free Cash Flow ratio
-6.65-6.17-16.57-11.65-16.28-8.99-9.70-7.29-14.11
Price/Earnings Growth ratio
N/A-1.562.44-0.80-1.07-6.53-0.383.430.81
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/A100%73.87%-83.82%N/A40.86%86.93%
Operating Profit Margin
N/AN/AN/A-1055.41%-1815.08%-5618.53%N/A-3957.33%-1435.24%
Pretax Profit Margin
N/AN/AN/A-1029.39%-1814.94%-5490.37%N/A-3867.06%-1422.17%
Net Profit Margin
N/AN/AN/A-1049.02%-1788.82%-5362.21%N/A-3867.06%-1418.92%
Effective Tax Rate
N/A-2.21%-1.55%-1.90%1.43%2.33%N/AN/A-1.73%
Return on Assets
-57.77%-51.92%-50.82%-44.45%-34.33%-30.75%-67.38%-31.49%-47.64%
Return On Equity
46.65%-56.48%-58.80%-50.77%-36.59%-33.39%-79.43%-41.68%-54.78%
Return on Capital Employed
-62.21%-56.87%-57.90%-49.62%-36.61%-34.04%-83.87%-34.04%-53.76%
Liquidity Ratios
Current Ratio
N/AN/A8.699.84N/AN/AN/A17.769.27
Quick Ratio
14.8514.018.699.8420.1117.767.4017.519.27
Cash ratio
14.6213.748.362.122.502.732.172.732.43
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
291.68522.56313.68N/A732.56437.55532.03N/A366.28
Cash Conversion Cycle
N/AN/AN/AN/A-732.56-437.55N/AN/AN/A
Debt Ratios
Debt Ratio
2.15N/AN/AN/AN/A0.000.010.07N/A
Debt Equity Ratio
-1.74N/AN/AN/AN/A0.000.010.08N/A
Long-term Debt to Capitalization
2.34N/AN/AN/AN/AN/AN/A0.02N/A
Total Debt to Capitalization
2.34N/AN/AN/AN/A0.000.010.03N/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
-0.24N/AN/AN/AN/A-32.59-39.64-7.87N/A
Company Equity Multiplier
-0.801.081.151.141.061.081.171.081.10
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/A-8.03-16.00-46.34N/A-32.64-12.01
Free Cash Flow / Operating Cash Flow Ratio
1.041.101.021.001.011.011.011.011.01
Cash Flow Coverage Ratio
-0.24N/AN/AN/AN/A-32.59-39.64-7.87N/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/A-32.59-39.64-32.59N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A